Ri-Hua Xie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ri-Hua Xie has a total of 292 co-authors. Here are the top co-authors by number of shared publications:
Daniel Krewski
School of Epidemiology and Public Health, Faculty of Medicine University of Ottawa Ottawa Ontario Canada
25 shared publicationsShi Wu Wen
School of Epidemiology and Public Health, Faculty of Medicine University of Ottawa Ottawa Ontario Canada
25 shared publications- Shi Wu Wen
Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada
13 shared publications Lepeng Zhou
Microbiome Medicine Center, Department of Laboratory Medicine, Zhujiang Hospital Southern Medical University Guangzhou Guangdong China
10 shared publicationsChuhui Zhou
The Affiliated Foshan Women and Children Hospital, School of Nursing, Guangdong Medical University, Foshan, Guangdong, China; School of Nursing, Southern Medical University, Guangzhou, Guangdong, China
9 shared publicationsJingfen Chen
School of Nursing, Southern Medical University, Guangzhou, PR China
9 shared publications
Latest Publications
- Open Access
- 11 November 2026
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28, e108128
Digital Health Interventions for Pregnancy- and Childbirth-Related Posttraumatic Stress Disorder Symptoms in Postpartum Women: Systematic Review and Meta-Analysis
Background: Pregnancy- or childbirth-related traumatic experiences may lead to posttraumatic stress disorder (PTSD) symptoms during the postpartum period, adversely affecting women and their families. Digital health interventions may improve access to psychological support; however, evidence of their effectiveness for pregnancy- and childbirth-related posttraumatic stress disorder (PCR-PTSD) symptoms remains limited and has not been systematically synthesized. Objective: This study aimed to evaluate the effects of digital health interventions on PCR-PTSD symptoms in postpartum women, with depressive and anxiety symptoms as secondary outcomes. Methods: We searched 7 English-language and 4 Chinese-language databases from inception through April 30, 2026, to identify randomized controlled trials (RCTs) evaluating digital health interventions in women who had experienced pregnancy- or childbirth-related traumatic events and were assessed for PTSD symptoms during the postpartum period. Risk of bias was assessed using the Cochrane Risk of Bias 2 tool. Effect estimates were pooled using random-effects models with restricted maximum likelihood estimation and Hartung-Knapp adjustments and reported as standardized mean differences (SMDs) with 95% CIs. Statistical heterogeneity, 95% prediction intervals (PIs), subgroup effects, and the robustness of pooled estimates were also examined. Results: A total of 10 RCTs involving 1026 participants were included. Of these, 9 trials (809 participants) reported PTSD symptom outcomes immediately after the intervention, and 6 trials (413 participants) reported outcomes at follow-up. Digital health interventions were associated with lower PTSD symptom severity immediately after the intervention (SMD −0.59, 95% CI −0.98 to −0.19, 95% PI −1.72 to 0.54; P=.01), with substantial heterogeneity (I²=79.86%). However, the pooled effect was not statistically significant at the longest available follow-up (SMD −0.36, 95% CI −1 to 0.27, 95% PI −2.03 to 1.31; P=.20). All 95% PIs crossed the null. No statistically significant subgroup differences were observed by PTSD-related eligibility requirements, delivery modality, intervention duration, or trauma context. A statistically significant subgroup difference was observed by health care provider involvement (Q=14.46; P<.001); however, this exploratory finding should be interpreted cautiously. Sensitivity analyses supported the robustness of the pooled effect on PTSD symptoms immediately after the intervention. Conclusions: Digital health interventions may be associated with short-term reductions in PTSD, depressive, and anxiety symptoms among women with pregnancy- or childbirth-related trauma. However, substantial heterogeneity and PIs crossing the null limit confidence in these effects. Further well-designed trials with clinically interpretable outcomes and longer follow-up are needed. Trial Registration: PROSPERO CRD420261290528; https://www.crd.york.ac.uk/PROSPERO/view/CRD420261290528
- 11 November 2026
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28, e108128
Open AccessDigital Health Interventions for Pregnancy- and Childbirth-Related Posttraumatic Stress Disorder Symptoms in Postpartum Women: Systematic Review and Meta-Analysis
Background: Pregnancy- or childbirth-related traumatic experiences may lead to posttraumatic stress disorder (PTSD) symptoms during the postpartum period, adversely affecting women and their families. Digital health interventions may improve access to psychological support; however, evidence of their effectiveness for pregnancy- and childbirth-related posttraumatic stress disorder (PCR-PTSD) symptoms remains limited and has not been systematically synthesized. Objective: This study aimed to evaluate the effects of digital health interventions on PCR-PTSD symptoms in postpartum women, with depressive and anxiety symptoms as secondary outcomes. Methods: We searched 7 English-language and 4 Chinese-language databases from inception through April 30, 2026, to identify randomized controlled trials (RCTs) evaluating digital health interventions in women who had experienced pregnancy- or childbirth-related traumatic events and were assessed for PTSD symptoms during the postpartum period. Risk of bias was assessed using the Cochrane Risk of Bias 2 tool. Effect estimates were pooled using random-effects models with restricted maximum likelihood estimation and Hartung-Knapp adjustments and reported as standardized mean differences (SMDs) with 95% CIs. Statistical heterogeneity, 95% prediction intervals (PIs), subgroup effects, and the robustness of pooled estimates were also examined. Results: A total of 10 RCTs involving 1026 participants were included. Of these, 9 trials (809 participants) reported PTSD symptom outcomes immediately after the intervention, and 6 trials (413 participants) reported outcomes at follow-up. Digital health interventions were associated with lower PTSD symptom severity immediately after the intervention (SMD −0.59, 95% CI −0.98 to −0.19, 95% PI −1.72 to 0.54; P=.01), with substantial heterogeneity (I²=79.86%). However, the pooled effect was not statistically significant at the longest available follow-up (SMD −0.36, 95% CI −1 to 0.27, 95% PI −2.03 to 1.31; P=.20). All 95% PIs crossed the null. No statistically significant subgroup differences were observed by PTSD-related eligibility requirements, delivery modality, intervention duration, or trauma context. A statistically significant subgroup difference was observed by health care provider involvement (Q=14.46; P<.001); however, this exploratory finding should be interpreted cautiously. Sensitivity analyses supported the robustness of the pooled effect on PTSD symptoms immediately after the intervention. Conclusions: Digital health interventions may be associated with short-term reductions in PTSD, depressive, and anxiety symptoms among women with pregnancy- or childbirth-related trauma. However, substantial heterogeneity and PIs crossing the null limit confidence in these effects. Further well-designed trials with clinically interpretable outcomes and longer follow-up are needed. Trial Registration: PROSPERO CRD420261290528; https://www.crd.york.ac.uk/PROSPERO/view/CRD420261290528
- Open Access
- 28 July 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Digital Health Interventions for Pregnancy- and Childbirth-Related Posttraumatic Stress Disorder Symptoms in Postpartum Women: Systematic Review and Meta-Analysis (Preprint)
BACKGROUND Pregnancy- or childbirth-related traumatic experiences may lead to posttraumatic stress disorder (PTSD) symptoms during the postpartum period, adversely affecting women and their families. Digital health interventions may improve access to psychological support; however, evidence of their effectiveness for pregnancy- and childbirth-related posttraumatic stress disorder (PCR-PTSD) symptoms remains limited and has not been systematically synthesized. OBJECTIVE This study aimed to evaluate the effects of digital health interventions on PCR-PTSD symptoms in postpartum women, with depressive and anxiety symptoms as secondary outcomes. METHODS We searched 7 English-language and 4 Chinese-language databases from inception through April 30, 2026, to identify randomized controlled trials (RCTs) evaluating digital health interventions in women who had experienced pregnancy- or childbirth-related traumatic events and were assessed for PTSD symptoms during the postpartum period. Risk of bias was assessed using the Cochrane Risk of Bias 2 tool. Effect estimates were pooled using random-effects models with restricted maximum likelihood estimation and Hartung-Knapp adjustments and reported as standardized mean differences (SMDs) with 95% CIs. Statistical heterogeneity, 95% prediction intervals (PIs), subgroup effects, and the robustness of pooled estimates were also examined. RESULTS A total of 10 RCTs involving 1026 participants were included. Of these, 9 trials (809 participants) reported PTSD symptom outcomes immediately after the intervention, and 6 trials (413 participants) reported outcomes at follow-up. Digital health interventions were associated with lower PTSD symptom severity immediately after the intervention (SMD −0.59, 95% CI −0.98 to −0.19, 95% PI −1.72 to 0.54; P=.01), with substantial heterogeneity (I²=79.86%). However, the pooled effect was not statistically significant at the longest available follow-up (SMD −0.36, 95% CI −1 to 0.27, 95% PI −2.03 to 1.31; P=.20). All 95% PIs crossed the null. No statistically significant subgroup differences were observed by PTSD-related eligibility requirements, delivery modality, intervention duration, or trauma context. A statistically significant subgroup difference was observed by health care provider involvement (Q=14.46; P<.001); however, this exploratory finding should be interpreted cautiously. Sensitivity analyses supported the robustness of the pooled effect on PTSD symptoms immediately after the intervention. CONCLUSIONS Digital health interventions may be associated with short-term reductions in PTSD, depressive, and anxiety symptoms among women with pregnancy- or childbirth-related trauma. However, substantial heterogeneity and PIs crossing the null limit confidence in these effects. Further well-designed trials with clinically interpretable outcomes and longer follow-up are needed. CLINICALTRIAL PROSPERO CRD420261290528; https://www.crd.york.ac.uk/PROSPERO/view/CRD420261290528
- 28 July 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessDigital Health Interventions for Pregnancy- and Childbirth-Related Posttraumatic Stress Disorder Symptoms in Postpartum Women: Systematic Review and Meta-Analysis (Preprint)
BACKGROUND Pregnancy- or childbirth-related traumatic experiences may lead to posttraumatic stress disorder (PTSD) symptoms during the postpartum period, adversely affecting women and their families. Digital health interventions may improve access to psychological support; however, evidence of their effectiveness for pregnancy- and childbirth-related posttraumatic stress disorder (PCR-PTSD) symptoms remains limited and has not been systematically synthesized. OBJECTIVE This study aimed to evaluate the effects of digital health interventions on PCR-PTSD symptoms in postpartum women, with depressive and anxiety symptoms as secondary outcomes. METHODS We searched 7 English-language and 4 Chinese-language databases from inception through April 30, 2026, to identify randomized controlled trials (RCTs) evaluating digital health interventions in women who had experienced pregnancy- or childbirth-related traumatic events and were assessed for PTSD symptoms during the postpartum period. Risk of bias was assessed using the Cochrane Risk of Bias 2 tool. Effect estimates were pooled using random-effects models with restricted maximum likelihood estimation and Hartung-Knapp adjustments and reported as standardized mean differences (SMDs) with 95% CIs. Statistical heterogeneity, 95% prediction intervals (PIs), subgroup effects, and the robustness of pooled estimates were also examined. RESULTS A total of 10 RCTs involving 1026 participants were included. Of these, 9 trials (809 participants) reported PTSD symptom outcomes immediately after the intervention, and 6 trials (413 participants) reported outcomes at follow-up. Digital health interventions were associated with lower PTSD symptom severity immediately after the intervention (SMD −0.59, 95% CI −0.98 to −0.19, 95% PI −1.72 to 0.54; P=.01), with substantial heterogeneity (I²=79.86%). However, the pooled effect was not statistically significant at the longest available follow-up (SMD −0.36, 95% CI −1 to 0.27, 95% PI −2.03 to 1.31; P=.20). All 95% PIs crossed the null. No statistically significant subgroup differences were observed by PTSD-related eligibility requirements, delivery modality, intervention duration, or trauma context. A statistically significant subgroup difference was observed by health care provider involvement (Q=14.46; P<.001); however, this exploratory finding should be interpreted cautiously. Sensitivity analyses supported the robustness of the pooled effect on PTSD symptoms immediately after the intervention. CONCLUSIONS Digital health interventions may be associated with short-term reductions in PTSD, depressive, and anxiety symptoms among women with pregnancy- or childbirth-related trauma. However, substantial heterogeneity and PIs crossing the null limit confidence in these effects. Further well-designed trials with clinically interpretable outcomes and longer follow-up are needed. CLINICALTRIAL PROSPERO CRD420261290528; https://www.crd.york.ac.uk/PROSPERO/view/CRD420261290528
- Open Access
- 20 May 2026
- Published by Elsevier in Cell Metabolism
- Vol. 38 (9) , 1835-1847.e7
Hyocholic acids shape neonatal immune tolerance and microbiota assembly
- 20 May 2026
- Published by Elsevier in Cell Metabolism
- Vol. 38 (9) , 1835-1847.e7
Open AccessHyocholic acids shape neonatal immune tolerance and microbiota assembly
- Open Access
- 6 May 2026
- Published by Taylor & Francis in European Journal of Psychotraumatology
- Vol. 17 (1) , 2662053
Understanding how adverse childhood experiences influence the development of postpartum post-traumatic stress disorder: a qualitative study in China
1. Adverse childhood experiences (ACEs) encompass a range of harmful events occurring before the age of 18 that can threaten an individual's survival, development, and physiological and psychologic...
- 6 May 2026
- Published by Taylor & Francis in European Journal of Psychotraumatology
- Vol. 17 (1) , 2662053
Open AccessUnderstanding how adverse childhood experiences influence the development of postpartum post-traumatic stress disorder: a qualitative study in China
1. Adverse childhood experiences (ACEs) encompass a range of harmful events occurring before the age of 18 that can threaten an individual's survival, development, and physiological and psychologic...
- Open Access
- 24 April 2026
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 105 (6) , 1064-1074
Effects of vaginal microbiota transfer on social–emotional and neurodevelopment in cesarean‐born infants: 12‐month follow‐up of a pilot randomized clinical trial
Introduction: To evaluate the effects of vaginal microbiota transfer (VMT) on social–emotional development and to assess whether neurodevelopmental benefits observed at 6 months persist at 12 months in cesarean‐born infants. Material and Methods: This 12‐month follow‐up study extended a prior randomized, placebo‐controlled trial at a tertiary hospital in southern China. Cesarean‐born infants were randomly assigned in a 1:1 ratio to receive maternal vaginal fluid (VMT group) or sterile saline‐soaked gauze (Con group) immediately after delivery. Vaginally delivered mother–infant dyads served as a natural reference group (VD group). The primary endpoint of the original trial was infant neurodevelopment at 6 months. In this follow‐up, social–emotion and neurodevelopment at 12 months were assessed using the Ages and Stages Questionnaires: Social–Emotional, Second Edition (ASQ:SE‐2) and Third Edition (ASQ‐3). Lower ASQ:SE‐2 scores indicate better social–emotion skills, while higher ASQ‐3 scores indicate better neurodevelopmental performance. This trial was registered with the Chinese Clinical Trial Registry, ChiCTR2000031326. Results: A total of 210 mother–infant dyads were enrolled (VMT, Con, VD: n = 70 each) from December 10, 2020, to November 11, 2022. Infants in the VMT group had significantly lower ASQ:SE‐2 total scores than those in the Con group (31.01% decrease; mean difference [MD]: −9.24; 95% confidence interval [95% CI]: −16.04 to −2.45), with improvements in self‐regulation, social communication, and interaction with people. The VMT group also had higher ASQ‐3 scores in the personal–social subdomain (MD: 4.65; 95% CI: 0.15 to 9.15), but no significant difference in total ASQ‐3 scores (MD: 8.90; 95% CI, −2.9 to 20.70). No significant differences were found between the VMT and VD groups. The VMT group had a lower prevalence of social–emotional risk (adjusted RR: 0.39 [95% CI, 0.19 to 0.80]) than the Con group. Conclusions: This pilot randomized clinical trial suggests that VMT may be associated with improved social–emotional development at 12 months in cesarean‐born infants, although the neurodevelopmental benefits observed earlier appear to diminish over time. Given the small sample size and exploratory nature, the findings should be interpreted with caution. Larger, multi‐center randomized controlled trials with longer follow‐up are needed to confirm these results and further evaluate the VMT's effectiveness.
- 24 April 2026
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 105 (6) , 1064-1074
Open AccessEffects of vaginal microbiota transfer on social–emotional and neurodevelopment in cesarean‐born infants: 12‐month follow‐up of a pilot randomized clinical trial
Introduction: To evaluate the effects of vaginal microbiota transfer (VMT) on social–emotional development and to assess whether neurodevelopmental benefits observed at 6 months persist at 12 months in cesarean‐born infants. Material and Methods: This 12‐month follow‐up study extended a prior randomized, placebo‐controlled trial at a tertiary hospital in southern China. Cesarean‐born infants were randomly assigned in a 1:1 ratio to receive maternal vaginal fluid (VMT group) or sterile saline‐soaked gauze (Con group) immediately after delivery. Vaginally delivered mother–infant dyads served as a natural reference group (VD group). The primary endpoint of the original trial was infant neurodevelopment at 6 months. In this follow‐up, social–emotion and neurodevelopment at 12 months were assessed using the Ages and Stages Questionnaires: Social–Emotional, Second Edition (ASQ:SE‐2) and Third Edition (ASQ‐3). Lower ASQ:SE‐2 scores indicate better social–emotion skills, while higher ASQ‐3 scores indicate better neurodevelopmental performance. This trial was registered with the Chinese Clinical Trial Registry, ChiCTR2000031326. Results: A total of 210 mother–infant dyads were enrolled (VMT, Con, VD: n = 70 each) from December 10, 2020, to November 11, 2022. Infants in the VMT group had significantly lower ASQ:SE‐2 total scores than those in the Con group (31.01% decrease; mean difference [MD]: −9.24; 95% confidence interval [95% CI]: −16.04 to −2.45), with improvements in self‐regulation, social communication, and interaction with people. The VMT group also had higher ASQ‐3 scores in the personal–social subdomain (MD: 4.65; 95% CI: 0.15 to 9.15), but no significant difference in total ASQ‐3 scores (MD: 8.90; 95% CI, −2.9 to 20.70). No significant differences were found between the VMT and VD groups. The VMT group had a lower prevalence of social–emotional risk (adjusted RR: 0.39 [95% CI, 0.19 to 0.80]) than the Con group. Conclusions: This pilot randomized clinical trial suggests that VMT may be associated with improved social–emotional development at 12 months in cesarean‐born infants, although the neurodevelopmental benefits observed earlier appear to diminish over time. Given the small sample size and exploratory nature, the findings should be interpreted with caution. Larger, multi‐center randomized controlled trials with longer follow‐up are needed to confirm these results and further evaluate the VMT's effectiveness.
- Retracted
- 22 April 2026
- Published by Elsevier in Cell Host & Microbe
- Vol. 34 (5) , 942-958.e15
Vaginal microbiota transfer ameliorates cesarean-associated neurodevelopmental deficits in mice via N-bc2S1P synthesis on neonatal skin
- 22 April 2026
- Published by Elsevier in Cell Host & Microbe
- Vol. 34 (5) , 942-958.e15
RetractedVaginal microbiota transfer ameliorates cesarean-associated neurodevelopmental deficits in mice via N-bc2S1P synthesis on neonatal skin
- Open Access
- 30 November 2025
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 41 (1) , 2590871
Association between dietary antioxidant intakes and female infertility: evidence from the national health and nutrition examination survey 2013−2020
Approximately one in eight women aged 15-49 years seek medical care for infertility. Oxidative stress is a critical factor in female infertility. The Composite Dietary Antioxidant Index (CDAI) is a novel metric for assessing overall dietary antioxidant capacity. This study aimed to investigate the association between CDAI, its individual components, and infertility risk. A cross-sectional analysis was conducted using 2013-2020 National Health and Nutrition Examination Survey (NHANES) data. The CDAI was calculated based on dietary intake of vitamins A, C, E, zinc, selenium, and carotenoids. Weighted logistic regression models were used to assess associations between CDAI (and its components) and infertility. Restricted cubic spline (RCS) analysis was applied to evaluate potential non-linear relationships. Subgroup and sensitivity analyses were performed to test the robustness of the findings. A negative association between CDAI and infertility was observed (OR = 0.95; 95%CI [0.91-0.99], P = 0.014). Stratification by CDAI quartiles showed a consistent decreasing trend in infertility risk (Q4 vs. Q1: OR = 0.52; 95%CI [0.33-0.84], P for trend = 0.003). RCS analysis indicated a linear negative relationship between CDAI and infertility (P for non-linear = 0.278). Higher carotenoid intake was inversely associated with infertility risk, whereas intakes of vitamin A and C showed V-shaped, non-linear associations with infertility (P for non-linear < 0.05). These findings remained stable across subgroup and sensitivity analyses. CDAI is linearly and inversely associated with the prevalence of female infertility, highlighting the potential importance of antioxidant-rich diets in promoting women's reproductive health.
- 30 November 2025
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 41 (1) , 2590871
Open AccessAssociation between dietary antioxidant intakes and female infertility: evidence from the national health and nutrition examination survey 2013−2020
Approximately one in eight women aged 15-49 years seek medical care for infertility. Oxidative stress is a critical factor in female infertility. The Composite Dietary Antioxidant Index (CDAI) is a novel metric for assessing overall dietary antioxidant capacity. This study aimed to investigate the association between CDAI, its individual components, and infertility risk. A cross-sectional analysis was conducted using 2013-2020 National Health and Nutrition Examination Survey (NHANES) data. The CDAI was calculated based on dietary intake of vitamins A, C, E, zinc, selenium, and carotenoids. Weighted logistic regression models were used to assess associations between CDAI (and its components) and infertility. Restricted cubic spline (RCS) analysis was applied to evaluate potential non-linear relationships. Subgroup and sensitivity analyses were performed to test the robustness of the findings. A negative association between CDAI and infertility was observed (OR = 0.95; 95%CI [0.91-0.99], P = 0.014). Stratification by CDAI quartiles showed a consistent decreasing trend in infertility risk (Q4 vs. Q1: OR = 0.52; 95%CI [0.33-0.84], P for trend = 0.003). RCS analysis indicated a linear negative relationship between CDAI and infertility (P for non-linear = 0.278). Higher carotenoid intake was inversely associated with infertility risk, whereas intakes of vitamin A and C showed V-shaped, non-linear associations with infertility (P for non-linear < 0.05). These findings remained stable across subgroup and sensitivity analyses. CDAI is linearly and inversely associated with the prevalence of female infertility, highlighting the potential importance of antioxidant-rich diets in promoting women's reproductive health.
- 20 November 2025
- Published by Elsevier in Journal of Affective Disorders
- Vol. 395 (Pt A) , 120723
The association between adverse childhood experiences and postpartum post-traumatic stress disorder among women in China: A moderated mediation model of childbirth experiences and social support
- 20 November 2025
- Published by Elsevier in Journal of Affective Disorders
- Vol. 395 (Pt A) , 120723
The association between adverse childhood experiences and postpartum post-traumatic stress disorder among women in China: A moderated mediation model of childbirth experiences and social support
- Open Access
- 5 October 2025
- Published by Elsevier in World Allergy Organization Journal
- Vol. 18 (10)
Probiotic supplementation during pregnancy or infancy for the prevention of allergic rhinitis in infants: A systematic review and meta-analysis of Randomized controlled trials
- 5 October 2025
- Published by Elsevier in World Allergy Organization Journal
- Vol. 18 (10)
Open AccessProbiotic supplementation during pregnancy or infancy for the prevention of allergic rhinitis in infants: A systematic review and meta-analysis of Randomized controlled trials